Lung cancer
Conditions
Interventions
Experimental group:Heparin + intermittent pulse inflation pressurization
Sponsors
Southwest Hospital, Army Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18-65 years, regardless of gender; 2. Patients diagnosed with lung cancer by pathology and imaging and intend to undergo surgery; 3. Traditional thoracotomy or thoracoscopic surgery; 4. Those who have no previous history of thrombosis.
Exclusion criteria
Exclusion criteria: 1. Acute inflammatory skin disease and skin ulcer; 2. Acute venous thrombosis has occurred; 3. Deep thrombophlebitis; 4. Erysipelas; 5. Acute cardiopulmonary disease, pulmonary edema, arrhythmia, unstable hypertension; 6. Patients with pacemakers installed; 7. High risk of bleeding; 8. Patients who are contraindicated with unfractionated heparin or low molecular weight heparin.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VTE incidence; | — |
Secondary
| Measure | Time frame |
|---|---|
| To establish a clinical quantitative grading system for the risk of lower limb deep vein thrombosis during perioperative period of lung cancer;Establish risk assessment system and clinical management path for patients with lung cancer in thoracic surgery; | — |
Countries
China
Contacts
Public ContactAihong Huang
Southwest Hospital, Army Medical University
Outcome results
None listed